#507
Hasmukh Chudgar & family
Overview
- Source of Wealth
- Pharmaceuticals
- Industry
- Healthcare
- Residence
- Ahmedabad
- Marital Status
- Married
- Children
- 3
Biography
Low profile Hasmukh Chudgar founded generics maker Intas Pharmaceuticals in 1977.
Chudgar has long handed over operations to his sons Nimish and Binish, who run the $3.5 billion (revenue) company.
In August 2025, Intas Pharma acquired biosimilar company Udenyca from California-based Coherus Life Sciences for $558 million.
The company's portfolio includes an affordable drug to treat breast cancer called Eleftha, which is similar to Roche's Herceptin.
In 2022, the Abu Dhabi Investment Authority bought a 3% stake in Intas from Temasek.
About
Chudgar's third son Urmish heads the company's biopharma business and is a haematologist-oncologist.
The company's biggest markets are Europe and India.